Biotech · Private company
ABL Bio, Inc.
Track this companyFree. Adds ABL Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- ABL103Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- KEYTRUDA® (pembrolizumab)Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TaxanePhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ABL301Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- ABL503Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 6, 2025ClinicalTrials.gov NCT07158918 · fetched Nov 12, 2026
- This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Dec 31, 2022ClinicalTrials.gov NCT05756920 · fetched Nov 12, 2026
- This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Apr 1, 2021ClinicalTrials.gov NCT04762641 · fetched Nov 12, 2026